Predictors for Nasal Intermittent Positive Pressure Ventilation Failure for Premature Infants With Respiratory Distress Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

397 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-12-01

Study Completion Date

2024-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Non-invasive respiratory support methods have been widely used in premature babies with respiratory distress syndrome (RDS) which has changed the basic management of premature babies in the early period. According to the 2019 European Guidelines on RDS management, early nasal CPAP is recommended as first-line therapy in infants \<30 weeks of age who are at risk of RDS who do not require mechanical ventilation (MV). However, some of the premature babies have faced non-invasive ventilation failure. Remarkably, infants who experience non-invasive ventilation failure are at increased risk of death, pneumothorax, intraventricular hemorrhage, and bronchopulmonary dysplasia (BPD), among other morbidities. In non-invasive ventilation failure, although demographic factors such as small gestational age, low birth weight, and male gender play a role, it has been suggested that surfactant deficiency may also play an important role. The most frequently reported risk factor in predicting non-invasive failure in studies is the fraction of inspiring oxygen during the first hours of life. In addition, positive end-expiratory airway pressure (PEEP) required for patient stabilization was found to be a potential predictor. However, there are still limited data to predict non-invasive ventilation failure. "Which newborns are at high risk for non-invasive ventilation failure?" and "When should the surfactant be applied?". The study is a single-center, prospective study to evaluate prognostic factors, and most importantly to define the FiO2 threshold, which is an indicator of possible non-invasive ventilation failure in infants supported with nasal intermittent positive pressure ventilation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparison of Two Different NCPAP Methods in Preterm Infants With Respiratory Distress Syndrome

NCT03400670

Ventilatory Failure

UNKNOWN NA

Surfactant Versus Nasal Continuous Positive Airway Pressure (nCPAP) for Respiratory Distress Syndrome in the Newborn ≥ 35 Weeks of Gestation

NCT01306240

Acute Respiratory Distress Syndrome

TERMINATED PHASE3

NIPPV and nBiPAP Methods in Preterm Infants With Respiratory Distress Syndrome

NCT02901652

Prematurity Respiratory Distress Syndrome

UNKNOWN NA

Early NCPAP Before Surfactant Treatment in Very Preterm Infants With RDS

NCT01996670

Nasal Continuous Positive Airway Pressure, Preterm Infants, Surfactant Treatment, +2 more

COMPLETED

Ventilatory Management of the Preterm Neonate in the Delivery Room

NCT01255826

Respiratory Distress Syndrome, Newborn

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Distress Syndrome, Newborn Premature

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

non-invasive ventilation failure

babies who will be intubated in the first 72 hours

non-invasive ventilation

Intervention Type OTHER

Babies who will have or won't have non-invasive ventilation failure in the first 72 hoursof life, will be compared.

non-invasive ventilation success

babies who will not intubated in the first 72 hours

non-invasive ventilation

Intervention Type OTHER

Babies who will have or won't have non-invasive ventilation failure in the first 72 hoursof life, will be compared.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

non-invasive ventilation

Babies who will have or won't have non-invasive ventilation failure in the first 72 hoursof life, will be compared.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \<32 weeks preterm babies
* Those who have received nasal intermittent positive pressure ventilation

Exclusion Criteria

* Babies born\> 32 weeks
* Babies with congenital anomalies
* Babies who have intubated in the delivery room
* Babies whose parents refuse to participitate

Eligible Sex

ALL

Accepts Healthy Volunteers

No